|Day Low/High||2.00 / 2.07|
|52 Wk Low/High||1.15 / 7.95|
Investors in Conatus Pharmaceuticals Inc saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CNAT options chain for the new August 17th contracts and identified the following put contract of particular interest.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Conatus Pharmaceuticals Inc , where a total volume of 3,900 contracts has been traded thus far today, a contract volume which is representative of approximately 390,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 80.5% of CNAT's average daily trading volume over the past month, of 484,225 shares.
Investors in Conatus Pharmaceuticals Inc saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CNAT options chain for the new May 18th contracts and identified one put and one call contract of particular interest.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, AMC, CTRP, GSIT, ITGR, JNP, KFFB, MD, MDSO, NJR, VECO Downgrades: NEM, TFX, TTEC Initiations: CNAT, OTEL Read on to get TheStreet Quant Ratings' detailed report:
Investors eyeing a purchase of Conatus Pharmaceuticals Inc stock, but cautious about paying the going market price of $4.07/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2018 put at the $2.50 strike, which has a bid at the time of this writing of 10 cents.
The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 642,982 share decrease in total short interest for Conatus Pharmaceuticals Inc , to 1,461,190, a decrease of 30.56% since 10/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Pan-caspase Inhibitor IDN-7314 Reduces Liver Injury Due to Intestinal Bacteria Imbalance Resulting from Restricted Bile Flow in Mouse Model of PSC
Emricasan Improves and Sustains Key Functions in Cirrhotic Liver Cells
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.